A novel natural product, britanin, inhibits tumor growth of pancreatic cancer by suppressing nuclear factor- κB activation
In conclusion, br itanin has remarkable potential treatment effects against pancreatic cancer, and it could be developed as a new agent for pancreatic cancer chemotherapy.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Antidoxidants | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Drugs & Pharmacology | Pancreas | Pancreatic Cancer | Study | Toxicology